by Katrina Carr | Dec 9, 2020 | Biomarkers
Refining management of lung cancer: ctDNA testing comes of age BY CALEB RANS, PHARMD Lung cancer is the leading cause of cancer death, accounting for 18.4% of the total cancer deaths worldwide. Despite major advances in cancer care, lung cancer is associated with a...
by Katrina Carr | Nov 10, 2020 | Diagnosis & Therapy
COVID-19 crisis changed treatment for most lung cancer patients BY TED BOSWORTH credit: FG Trade/Getty Images At a cancer treatment center that tracked data prospectively, the COVID-19 epidemic led directly to treatment delays and reduced surveillance in the majority...
by Katrina Carr | Oct 6, 2020 | Diagnosis & Therapy
Lung cancer screening model identifies more at-risk African Americans BY WALTER ALEXANDER credit: THEPALMER/Getty Images A new model for lung cancer screening may ensure that African Americans at risk for lung cancer are no longer undercounted, according to...
by Katrina Carr | Aug 14, 2020 | Journeys
Lung cancer patients worry about access, research during COVID-19 BY NEIL OSTERWEIL credit: sanjeri/Getty Images Inability to get medical care when needed and the possibility of treatment interruption that could diminish chances for cure appear to be uppermost on the...
by Katrina Carr | Aug 6, 2020 | Biomarkers
Proteogenomic study reveals insights into early-stage lung cancer BY CALEB RANS, PHARMD FROM CELL / Novel insights into the underlying genetic and molecular architecture of lung adenocarcinoma may aid the management of patients with early-stage disease, according to...
